{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:12:42Z","timestamp":1791526362548,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009555","name":"Munich Center for Neurosciences \u2013 Brain and Mind, Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 870"],"award-info":[{"award-number":["SFB 870"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001870","name":"Fundacja na rzecz Nauki Polskiej","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003928","name":"Lungs for Life Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/007884"],"award-info":[{"award-number":["K\/ZDS\/007884"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/007882"],"award-info":[{"award-number":["K\/ZDS\/007882"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bmcl.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T12:11:10Z","timestamp":1554379870000},"page":"1298-1303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Four N-(E)-cinnamoyl (cinnamamide) derivatives of aminoalkanols with promising anticonvulsant and analgesic activity"],"prefix":"10.1016","volume":"29","author":[{"given":"Agnieszka","family":"Gunia-Krzy\u017cak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence M.","family":"Bareyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Marona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Waszkielewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.04.006_b0005","first-page":"664","article-title":"Epidemiology of epilepsy","volume":"82","author":"Sridharan","year":"2002","journal-title":"Curr Sci"},{"issue":"Suppl. 3","key":"10.1016\/j.bmcl.2019.04.006_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1528-1157.2001.042suppl.3027.x","article-title":"Management strategies for refractory localization-related seizures","volume":"42","author":"Brodie","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.bmcl.2019.04.006_b0015","first-page":"39","article-title":"Farmakologiczne leczenie b\u00f3lu neuropatycznego","volume":"7","author":"Wordliczek","year":"2011","journal-title":"Pol Przegl Neurol"},{"key":"10.1016\/j.bmcl.2019.04.006_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.bmcl.2019.04.006_b0025","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.2174\/092986711797200408","article-title":"Evaluation of anticonvulsants for possible use in neuropathic pain","volume":"18","author":"Waszkielewicz","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.006_b0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","article-title":"Moderate and severe traumatic brain injury in adults","volume":"7","author":"Maas","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bmcl.2019.04.006_b0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/ijms15011216","article-title":"Neuroprotective strategies for traumatic brain injury: improving clinical translation","volume":"15","author":"Kabadi","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2019.04.006_b0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","article-title":"Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies","volume":"31","author":"Loane","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmcl.2019.04.006_b0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/01.WNL.0000031432.05543.14","article-title":"Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the quality standards subcommittee of the American Academy of Neurology","volume":"60","author":"Chang","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bmcl.2019.04.006_b0050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0006-8993(00)02055-2","article-title":"Positive and negative modulation of the GABA(A) receptor and outcome after traumatic brain injury in rats","volume":"861","author":"O'Dell","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.bmcl.2019.04.006_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011383","article-title":"Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats","volume":"5","author":"Dash","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bmcl.2019.04.006_b0060","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3171\/2013.6.JNS13135","article-title":"Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury","volume":"119","author":"Yu","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.bmcl.2019.04.006_b0065","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cmdc.201500153","article-title":"Cinnamamide derivatives for central and peripheral nervous system disorders \u2013 a review of structure-activity relationships","volume":"10","author":"Gunia-Krzy\u017cak","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2019.04.006_b0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bmc.2016.11.014","article-title":"Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3","volume":"25","author":"Gunia-Krzy\u017cak","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.006_b0075","unstructured":"https:\/\/panache.ninds.nih.gov\/Model1C.aspx (accessed 25.01.2019)."},{"key":"10.1016\/j.bmcl.2019.04.006_b0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.seizure.2007.05.005","article-title":"Timed pentylenetetrazol infusion test: a comparative analysis with s.c.PTZ and MES models of anticonvulsant screening in mice","volume":"16","author":"Mandhane","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.bmcl.2019.04.006_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.eplepsyres.2010.09.002","article-title":"Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: correlation with other seizure and epilepsy models","volume":"92","author":"Rowley","year":"2010","journal-title":"Epilepsy Res"},{"issue":"Suppl. 3","key":"10.1016\/j.bmcl.2019.04.006_b0090","first-page":"S28","article-title":"Animal model studies application to human patients","volume":"69","author":"Holmes","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bmcl.2019.04.006_b0095","unstructured":"https:\/\/panache.ninds.nih.gov\/Model2A.aspx (accessed 25.01.2019)."},{"key":"10.1016\/j.bmcl.2019.04.006_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.bmcl.2019.04.006_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-1211(98)00016-3","article-title":"Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man","volume":"31","author":"Matagne","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.bmcl.2019.04.006_b0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-1211(98)00017-5","article-title":"Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy","volume":"31","author":"Hellier","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.bmcl.2019.04.006_b0115","unstructured":"https:\/\/panache.ninds.nih.gov\/Model4A.aspx (accessed 25.01.2019)."},{"key":"10.1016\/j.bmcl.2019.04.006_b0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cbdd.12943","article-title":"Physicochemical and biological evaluation of a cinnamamide derivative R, S-(2E)-1-(3-hydroxypiperidin-1-yl)-3-phenylprop-2-en-1-one (KM-608) for nervous system disorders","volume":"90","author":"Gunia-Krzy\u017cak","year":"2017","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmcl.2019.04.006_b0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuroscience.2011.12.041","article-title":"Tests and models of nociception and pain in rodents","volume":"211","author":"Barrot","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmcl.2019.04.006_b0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.bmcl.2019.04.006_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.bmcl.2019.04.006_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1930215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:53:45Z","timestamp":1777600425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X1930215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0960894X1930215X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.006","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four N-(E)-cinnamoyl (cinnamamide) derivatives of aminoalkanols with promising anticonvulsant and analgesic activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}